Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 18/20 | 1.00 |
| ▸ | CA9 | Q16790 | 16/20 | 0.86 |
| ▸ | CA12 | O43570 | 14/20 | 0.86 |
| ▸ | CA1 | P00915 | 15/20 | 0.64 |
| ▸ | CA7 | P43166 | 9/20 | 0.60 |
| ▸ | CA5A | P35218 | 8/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 8/20 | 0.59 |
| ▸ | CA4 | P22748 | 8/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 7/20 | 0.59 |
| ▸ | CA6 | P23280 | 6/20 | 0.59 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.59 |
| ▸ | CA3 | P07451 | 3/20 | 0.56 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.55 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3536600 | 0.97 | CA2 (0.95) | CA2CA9CA12CA1CA7 | |
| SCHEMBL22080317 | 0.87 | HTT (0.79) | CA2CA9CA12CA1CA7 | |
| SCHEMBL31571432 | 0.87 | CA2 (0.75) | CA2CA9CA12CA1CA7 | |
| SCHEMBL28159984 | 0.87 | CA2 (0.75) | CA2CA9CA12CA1CA7 | |
| SCHEMBL202948 | 0.85 | CA2 (0.81) | CA2CA9CA12CA1CA7 | |
| SCHEMBL28617028 | 0.82 | CA2 (0.73) | CA2CA9CA12CA1CA7 | |
| SCHEMBL8974243 | 0.82 | CA2 (0.71) | CA2CA9CA12CA1CA7 | |
| SCHEMBL20547699 | 0.80 | CA2 (0.64) | CA2CA9CA12CA1CA7 | |
| SCHEMBL6050803 | 0.80 | CA2 (0.69) | CA2CA9CA12CA1CA7 | |
| SCHEMBL6050841 | 0.80 | PTGS2 (0.70) | CA2CA9CA12CA1CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1329 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117643584-A | Preparation method of sulfachromone compound for candida albicans resistant medicine | 广西民族大学 | 2024-03-05 | — | — | CN | claimed |
| CN-114507179-B | Para-benzene ring butanamide rosemary compound serving as hyaluronidase inhibitor and application of para-benzene ring butanamide rosemary compound in beauty products | 北京青颜博识健康管理有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-114195714-A | Simple synthesis method of celecoxib | 山东铂源药业有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-111100092-A | Method for direct amination of thioamide-oriented aromatic hydrocarbon carbon-hydrogen | 宁夏大学 | 2020-05-05 | — | — | CN | claimed |
| CN-110240570-A | A kind of preparation method of SC 69124 sodium impurity | 浙江震元制药有限公司 | 2019-09-17 | — | — | CN | claimed |
| CN-109134391-A | A kind of acyl sulfonamides analog derivative and the preparation method and application thereof | 山东大学 | 2019-01-04 | — | — | CN | claimed |
| CN-102558056-B | Celecoxib and preparing method thereof | JIANGSU FANGSHENG PHARMACEUTICAL CO LTD | 2014-04-09 | — | — | CN | claimed |
| EP-2616440-A1 | ARYLOSULFONAMIDES FOR THE TREATMENT OF CNS DISEASES | Adamed sp. z o.o. (PL) | 2013-07-24 | — | — | EP | claimed |
| CN-101709045-B | Preparation method of thiophenol | UNIV ZHEJIANG | 2013-02-27 | — | — | CN | claimed |
| CN-102558056-A | Celecoxib and preparing method thereof | HUNAN FANGSHENG PHARMACEUTICAL CO LTD | 2012-07-11 | — | — | CN | claimed |
| CN-101993416-A | Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound | SHANGHAI INST MATERIA MEDICA | 2011-03-30 | — | — | CN | claimed |
| JP-4642242-B2 | — | — | 2011-03-02 | — | — | JP | claimed |
| CN-101709045-A | Preparation method of thiophenol | UNIV ZHEJIANG | 2010-05-19 | — | — | CN | claimed |
| EP-1155003-B1 | NOVEL GUANIDINE DERIVATIVES AS INHIBITORS OF CELL ADHESION | AVENTIS PHARMA GMBH (DE) | 2004-08-11 | — | — | EP | claimed |
| JP-2002536438-A | — | — | 2002-10-29 | — | — | JP | claimed |
| WO-2002068586-A2 | HIV/FIV PROTEASE INHIBITORS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2002-09-06 | — | — | WO | claimed |
| US-6340679-B1 | FOR INHIBITING BONE RESORPTION, OSTEOPOROSIS, TUMOR GROWTH OR TUMOR METASTASIS, INFLAMMATION, OR FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, RESTENOSIS, ARTERIOSCLEROSIS, NEPHROPATHIES, RETINOPATHIES OR RHEUMATOID ARTHRITIS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-01-22 | — | — | US | claimed |
| EP-1155003-A1 | NOVEL GUANIDINE DERIVATIVES AS INHIBITORS OF CELL ADHESION | Aventis Pharma Deutschland GmbH (DE) | 2001-11-21 | — | — | EP | claimed |
| WO-2000047564-A1 | NOVEL GUANIDINE DERIVATIVES AS INHIBITORS OF CELL ADHESION | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-08-17 | — | — | WO | claimed |
| EP-1028114-A1 | Novel guanidine derivatives as inhibitors of cell adhesion | Aventis Pharma Deutschland GmbH (DE) | 2000-08-16 | — | — | EP | claimed |